MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

13 Aug 2022 Evaluate
The sales is pegged at Rs. 643.89 millions for the June 2022 quarter. The mentioned figure indicates a decline of about -60.53% as against Rs. 1631.43 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -98.06 millions as compared to Net Profit of Rs. 231.98 millions of corresponding quarter ended June 2021Operating profit for the quarter ended June 2022 decreased to 3.76 millions as compared to 457.24 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 643.89 1631.43 -60.53 643.89 1631.43 -60.53 5198.74 5631.78 -7.69
Other Income 8.01 11.44 -29.98 8.01 11.44 -29.98 51.98 34.53 50.54
PBIDT 3.76 457.24 -99.18 3.76 457.24 -99.18 1196.83 1245.63 -3.92
Interest 48.50 49.62 -2.26 48.50 49.62 -2.26 188.75 111.62 69.10
PBDT -44.74 407.62 -110.98 -44.74 407.62 -110.98 1008.08 1134.01 -11.10
Depreciation 79.34 79.95 -0.76 79.34 79.95 -0.76 321.52 222.82 44.30
PBT -124.08 327.67 -137.87 -124.08 327.67 -137.87 686.56 911.19 -24.65
TAX -26.02 95.69 -127.19 -26.02 95.69 -127.19 6.18 301.55 -97.95
Deferred Tax -26.02 25.69 -201.28 -26.02 25.69 -201.28 -143.02 141.09 -201.37
PAT -98.06 231.98 -142.27 -98.06 231.98 -142.27 680.38 609.64 11.60
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 0.58 28.03 -97.92 0.58 28.03 -97.92 23.02 22.12 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..